SS
EIKN

Steve Schonfeld’s Eikon Therapeutics EIKN Stock Holding History

Steve Schonfeld’s Portfolio EIKN Stock Details EIKN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.35M Buy
+179,775
New +$1.84M 0.01% 986

Other funds holding EIKN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
MC
Merck & Co Rahway, New Jersey $526M AUM 175.27% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Steve Schonfeld's EIKN Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Eikon Therapeutics (EIKN) in Q2 2026: 179,775 shares worth $2.35M. The stake represents 0.01% of the portfolio and ranks #986 among its holdings.

76 funds tracked by Wall St. Rank hold EIKN as of Q2 2026.

  • Steve Schonfeld held 179,775 shares of Eikon Therapeutics worth $2.35M as of Q2 2026.
  • Eikon Therapeutics was a new Steve Schonfeld position in Q2 2026.
  • Eikon Therapeutics made up 0.01% of Steve Schonfeld's portfolio in Q2 2026, its #986 holding.
  • 76 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.